Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 141 for your search:
Drug:
hydroxyurea
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Autologous Stem Cell Reinfusion Following ARA-C/BCNU for CML in Blast Crisis
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
NCI-D82-018-544
, DFCI-80051, DFCI-CML
2.
Phase III Combination Chemotherapy with BHD (BCNU/DTIC/HU) vs BHD-V (BCNU/DTIC/HU/VCR) for Disseminated Malignant Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7216
3.
Phase III Study of Chemotherapy with BCNU/HU/DTIC and Immunotherapy with BCG for Disseminated Malignant Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7424/25
4.
Phase III Chemotherapy with BHD (BCNU/DTIC/HU) with or without BCG Immunotherapy for High-Risk Melanoma Patients
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7521
5.
Phase III Chemotherapy with COAP (ARA-C/VCR/CTX/PRED) and HU plus Splenectomy with or without BCG Immunotherapy for Chronic Myelogenous Leukemia (Summary Last Modified 07/97)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7522
, MDAR-25
6.
Phase III Chemotherapy with BHD (BCNU/HU/DTIC) and Levamisole Immunotherapy vs DTIC/ACT-D for Disseminated Melanoma (Summary Last Modified 07/97)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7727/28
7.
Phase III High-Dose HOAP (VCR/PRED/HU/ARA-C) Induction and Maintenance for the Blastic Phase of Chronic Granulocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7835
8.
Phase III Maintenance Therapy with VCR/MTX/BCNU/TG/CTX/HU/DNM for Adult Acute Nonlymphocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
Protocol IDs:
WCG-123
9.
Phase III Maintenance Therapy with C. parvum vs VCR/MTX/BCNU/TG/CTX/HU/DNM for Adult Acute Nonlymphocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
WCG-123R
10.
Phase III Trial of Chemotherapy with Hydroxyurea plus Radiotherapy Followed by Surgery for Intracranial Gliomas
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
over 15
Sponsor:
Protocol IDs:
WCG-813
11.
Phase III Chemotherapy with MOF-Strep (MeCCNU/VCR/5-FU/SZC) vs 5-FU/HU for Dukes C/D or Recurrent Advanced Colorectal Adenocarcinoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-2281
12.
Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
15 to 65
Sponsor:
NCI
Protocol IDs:
EST-2483
13.
Phase III Study of Radiotherapy plus HU/BCNU vs HU/PCB/CCNU/VCR for Primary Malignant Brain Tumors
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
15 and over
Sponsor:
Protocol IDs:
NCOG-6G61
14.
Phase III Study of Radiotherapy plus Chemotherapy with COMP vs Modified LSA2-L2 for non-Hodgkin's Lymphoma in Children
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
under 18
Sponsor:
NCI
Protocol IDs:
CCG-551
15.
Phase III Comparison of HU vs MNI as an Adjunct to Radiotherapy for Stage IIB/III/IVA Cervical Carcinoma with Negative Para-Aortic Nodes
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-56
16.
Phase III Radiotherapy plus Chemotherapy with HU, Followed by CACP vs No Further Treatment for Squamous Cell Carcinoma of the Cervix Metastatic to the High Common Iliac or Para-Aortic Lymph Nodes
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-59
17.
Phase III DAT (DNM/ARA-C/TG) vs AAT (AMSA/ARA-C/TG) for Induction with or without Maintenance Chemotherapy in Adult ANLL
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
MSKCC-8112
, NCI-C82-1519
18.
Phase III Induction (VCR/PRED/DNM), Consolidation (ARA-C/L-ASP plus CTX/DNM/VCR/PRED), and Maintenance (6-MP/MTX) for Adult ALL, with Salvage Therapy (VM-26/ARA-C) for Failures
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
Protocol IDs:
UCCRC-3583
, ICC-82L3, NCI-D82-014-968
19.
Phase III Chemotherapy with HU/6-MP/PRED vs HU/6-MP/PRED/VCR and DNM for Resistant Chronic Granulocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7331
20.
Phase III Chemotherapy with DNM/HU/6-MP/CTX/PRED and Immunotherapy with MER-BCG for Resistant Chronic Granulocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7631
21.
Phase III Comparison of Chemotherapy with DTIC vs DTIC/CCNU/VCR vs DTIC/BCNU/VCR vs DTIC/BCNU/HU for Metastatic Melanoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
CENOG-7130
22.
Phase III Combination Chemotherapy with ARA-C/RBD/VCR/PRED for Adults with Chronic Myelogenous Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
under 50
Sponsor:
Protocol IDs:
MDA-DT-7978
, NCI-V84-0021
23.
Phase III Randomized Study of Conventional Radiotherapy plus Chemotherapy with VCR/PRED/CCNU vs Conventional Radiotherapy plus Chemotherapy with VCR/MePRDL/CCNU/PCB/HU/CACP/ARA-C/DTIC in Young Patients with Previously Untreated High-Grade Astrocytomas Located Intracranially Outside the Brain Stem or in the Spinal Cord
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
CCG-945
24.
Phase III Randomized Comparison of 8-Drugs-in-One-Day Chemotherapy (CACP/PCB/CCNU/VCR/CTX/MePRDL/HU/ARA-C) Before and After Standard Radiotherapy vs Standard Radiotherapy plus VCR Followed by VCR/CCNU/PRED in Children with Unfavorable Medulloblastoma and Other Primitive Neuroectodermal Tumors
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
CCG-921
25.
Phase III Randomized Comparison of 5-FU/CACP vs HU As Potentiators of Radiotherapy in Patients with Stages IIB, III, and IVA Carcinoma of the Cervix with Negative Para-Aortic Nodes
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
NCI
Protocol IDs:
GOG-85
, SWOG-8695
Select All on Page
1
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®
Mobile | Español
Mobile | Español
